Andrew J. Last - 01 Sep 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Operating Officer
Signature
/s/ Andrew J. Last
Issuer symbol
BIO
Transactions as of
01 Sep 2021
Net transactions value
-$1,397,668
Form type
4
Filing time
03 Sep 2021, 17:05:47 UTC
Previous filing
28 Jun 2021
Next filing
02 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $598,480 +2,000 +156% $299.24 3,282 01 Sep 2021 Direct F1
transaction BIO Bio-Rad A Common Stock Sale $609,202 -750 -23% $812.27 2,532 01 Sep 2021 Direct F2
transaction BIO Bio-Rad A Common Stock Sale $529,361 -651 -26% $813.15 1,881 01 Sep 2021 Direct F3
transaction BIO Bio-Rad A Common Stock Sale $487,640 -599 -32% $814.09 1,282 01 Sep 2021 Direct F4
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +902 +70% $0.000000 2,184 02 Sep 2021 Direct F5
transaction BIO Bio-Rad A Common Stock Tax liability $369,945 -448 -21% $825.77 1,736 02 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +2,532 $0.000000 2,532 01 Sep 2021 Bio-Rad A Common Stock 2,532 $0.000000 Direct F6, F7
transaction BIO Non-Qualified Stock Option (right to buy) Award $0 +2,532 $0.000000 2,532 01 Sep 2021 Bio-Rad A Common Stock 2,532 $814.95 Direct F8
transaction BIO Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,000 -40% $0.000000 3,000 01 Sep 2021 Bio-Rad A Common Stock 2,000 $299.24 Direct F9
transaction BIO Restricted Stock Units Options Exercise $0 -902 -25% $0.000000 2,708 02 Sep 2021 Bio-Rad A Common Stock 902 $0.000000 Direct F6, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 13.9278 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $811.70 to $812.69, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $812.71 to $813.34, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $814.02 to $814.11, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 Shares of Class A common stock acquired on the vesting of restricted stock units.
F6 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F7 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F8 The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
F9 The option, representing a right to purchase a total of 5,000 shares, became exercisable in five equal annual installments beginning on April 29, 2020, which was the first anniversary of the date on which the option was granted.
F10 On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.